15-52789404-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004498.4(ONECUT1):āc.481A>Cā(p.Met161Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000159 in 1,613,676 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00018 ( 1 hom., cov: 32)
Exomes š: 0.00016 ( 0 hom. )
Consequence
ONECUT1
NM_004498.4 missense
NM_004498.4 missense
Scores
4
15
Clinical Significance
Conservation
PhyloP100: 4.93
Genes affected
ONECUT1 (HGNC:8138): (one cut homeobox 1) This gene encodes a member of the Cut homeobox family of transcription factors. Expression of the encoded protein is enriched in the liver, where it stimulates transcription of liver-expressed genes, and antagonizes glucocorticoid-stimulated gene transcription. This gene may influence a variety of cellular processes including glucose metabolism, cell cycle regulation, and it may also be associated with cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.020537078).
BS2
High AC in GnomAd4 at 27 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ONECUT1 | NM_004498.4 | c.481A>C | p.Met161Leu | missense_variant | 1/2 | ENST00000305901.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ONECUT1 | ENST00000305901.7 | c.481A>C | p.Met161Leu | missense_variant | 1/2 | 1 | NM_004498.4 | P1 | |
ONECUT1 | ENST00000561401.3 | n.50+1625A>C | intron_variant, non_coding_transcript_variant | 3 | |||||
ONECUT1 | ENST00000570208.2 | upstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000178 AC: 27AN: 152104Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
27
AN:
152104
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000305 AC: 76AN: 249564Hom.: 0 AF XY: 0.000355 AC XY: 48AN XY: 135050
GnomAD3 exomes
AF:
AC:
76
AN:
249564
Hom.:
AF XY:
AC XY:
48
AN XY:
135050
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000157 AC: 229AN: 1461572Hom.: 0 Cov.: 31 AF XY: 0.000171 AC XY: 124AN XY: 727096
GnomAD4 exome
AF:
AC:
229
AN:
1461572
Hom.:
Cov.:
31
AF XY:
AC XY:
124
AN XY:
727096
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000178 AC: 27AN: 152104Hom.: 1 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74298
GnomAD4 genome
AF:
AC:
27
AN:
152104
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
74298
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
27
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 31, 2023 | The c.481A>C (p.M161L) alteration is located in exon 1 (coding exon 1) of the ONECUT1 gene. This alteration results from a A to C substitution at nucleotide position 481, causing the methionine (M) at amino acid position 161 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Loss of catalytic residue at M161 (P = 0.0574);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at